GeneType identifies 79.5% at risk of serious disease
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Genetic Technologies Limited announces that its geneType test identifies a significant percentage of individuals at risk for serious diseases, highlighting its effectiveness in preventive healthcare. The results indicate that a large portion of those tested showed elevated risks for various conditions, emphasizing the importance of early detection and intervention. The announcement underscores the advantages of geneType's non-invasive testing approach and its potential to improve health outcomes through personalized care.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- Genetic Technologies Expands Operational Capacity in North America
- GTG Expands Operational Capacity in North America
- GeneType and Stayhealthy Announce Landmark Distribution Agre
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
- Launch of test for 100% risk of breast and ovarian cancer
Later from Genetic Technologies
- GeneType to Enter Canadian and New Zealand Markets
- Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
- Strategic restructure to focus on USA sales growth
- Entitlement Offer Prospectus
- Global launch of geneType on EasyDNA platform
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies